Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and⦠read more
Healthcare
Diagnostics & Research
6 years
USD
Exclusive to Premium users
$20.50
Price+15.23%
$2.71
$30.697m
Small
-
Premium
Premium
-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow Margin$20.570m
-
1y CAGR-
3y CAGR-
5y CAGR-$1.801m
-
1y CAGR-
3y CAGR-
5y CAGR-$1.21
-
1y CAGR-
3y CAGR-
5y CAGR$12.288m
$18.816m
Assets$6.528m
Liabilities$2.611m
Debt13.9%
-5.1x
Debt to EBITDA$565k
-
1y CAGR-
3y CAGR-
5y CAGR